International Quality & Productivity Center (IQPC) will be holding its 6th Annual Developing IP Strategies for Crystalline Forms conference from December 7-8, 2010 in London, England. The conference will allow attendees to:
• Protect business critical patents at an international level with updates regarding recent developments from around the world;
• Protect new patent revenue through implementation of correct concepts for true innovative forms;
• Prevent incoming attacks by understanding requirements to support claims;
• Capitalize on patents in emerging markets to increase product profitability through appropriate drafting for each country; and
• Maximize patent protection and benchmark protection strategies with leading companies through implementation of a successful application strategy.
In particular, the conference will offer presentations on the following topics:
• Bird's eye view of the international patent system to understand the impact of recent developments on pharmaceutical patenting;
• Case update: Patenting new polymorphs: True innovation or reissue of prior art?
• Case update: Defining a strategy to address IP issues for a polymorph, salt, hydrate, impurity patent: A generic perspective;
• Case update: Polymorphism -- Understanding the examination procedure and experience at the DPMA;
• Case update: Balance sheet for polymorph patents: Creation, enforceability, misuse & challenges;
• Bridging the gap between the knowledge of salt and polymorph scientists and patent attorneys -- What do scientists need to know about patententability? What should patent attorneys understand about the drug product development process?
• Developing an optimal communication strategy between lawyers and experimentalists to achieve appropriate detail in your patent applications and avoid refute;
• Exploring the role of an IP specialist in industry: A personal view;
• Panel discussion: Insights into developments on patenting and litigation of crystalline forms and polymorphs from around the world;
• Case update: Gaining paediatric exclusivity to extend pharmaceutical patents and gain exclusivity in Europe;
• Insights and evaluation of pharmaceutical SPCs to avoid unnecessary litigation;
• Case update: A generic perspective of patenting crystalline forms;
• Case update: Exploring the patentability of crystalline forms to develop a successful patent strategy;
• Selecting the correct polymorphs by addressing various global IP regulatory requirements;
• Case update: Patenting crystalline forms -- The European Patent Office approach;
• Exploring the impact of raising the bar at the EPO on your patent strategy; and
• Panel discussion: Outlook to the future of crystalline form patent litigation.
Three additional pre-conference workshops will be offered on December 6, 2010. Workshop A, entitled "The EPO -- Raising the bar? Successfully navigating the changing IP landscape to ensure robust patent applications and litigation" will be offered from 9:00 am to 11:30 am, Workshop B, entitled "Developing an effective IP infrastructure between the R&D and patent department -- How to retrieve patentable inventions out of big R&D departments and channelize them towards patents?" will be offered from 12:00 pm to 2:00 pm, and Workshop C, entitled "Guaranteeing your crystalline form patent is internationally protected through implementation of best practice strategies from around the world," will be offered from 3:00 pm to 5:30 pm.
The agenda for the Developing IP Strategies for Crystalline Forms conference can be found here (Day 1), here (Day 2), and here (pre-conference workshops). A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
Pricing for the conference and workshops can be found here. Those registering on or before November 5, 2010 will receive a discount of between £100 and £400 off the registration fee. Those interested in registering for the conference can do so here.
Patent Docs is a preferred blog of the Developing IP Strategies for Crystalline Forms conference.
Hi,
Do residents of CA, USA qualify for MCLE credits? If so, how many?
Please email me this info. as soon as possible at: [email protected]
Thank you.
Posted by: Amy Chao | October 27, 2010 at 12:09 PM